Advanced Hormone-refractory prostate cancer
Also known as: Hormone refractory, advanced Prostate cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01204 | Mitoxantrone | DNA topoisomerase 2-alpha | target |
| DB01204 | Mitoxantrone | Cytochrome P450 2E1 | enzyme |
| DB01204 | Mitoxantrone | P-glycoprotein 1 | transporter |
| DB01204 | Mitoxantrone | Multidrug resistance-associated protein 1 | transporter |
| DB01204 | Mitoxantrone | ATP-binding cassette sub-family G member 2 | transporter |
| DB01204 | Mitoxantrone | DNA | target |
| DB01204 | Mitoxantrone | Cytochrome P450 1B1 | enzyme |
| DB01204 | Mitoxantrone | Cytochrome P450 3A4 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|